Technology
Ceva, Inc. Announces First Quarter 2026 Financial Results
Published
7 hours agoon
By
Highlights strong licensing growth driven by integrated solutions and accelerating edge AI adoption
ROCKVILLE, Md., May 11, 2026 /PRNewswire/ — Ceva, Inc. (NASDAQ: CEVA), the leading licensor of silicon and software IP for the Smart Edge, today announced its financial results for the first quarter ended March 31, 2026.
First Quarter Highlights: *
Delivered total revenues of $27.0 million, up 11% year-over-yearLicensing and related revenues of $17.8 million, up 18% year-over-year and the highest in three yearsRoyalty revenues of $9.2 million, with smart edge royalties up 8% year-over-year, driven by record shipments in Wi-Fi, and strong contribution from cellular IoT, 5G infrastructure and automotive AISigned 14 IP licensing agreements, including several multi-technology engagements with existing customersSecured a major customer win for Bluetooth High Data Throughput (HDT) solution, including Ceva’s internally developed RF technology, demonstrating its system-level connectivity strategyExpanded customer engagements in 5G NTN and Ultra-Wideband, increasing value per designAI represented more than 20% of licensing and related revenues, with strong growth and key production milestones, including the Renesas R-Car V4H platform entering the 2026 Toyota RAV4, alongside a collaboration with NXP for its latest software-defined vehicle processors
*Unless otherwise stated, all comparisons are to first quarter 2025.
Amir Panush, Chief Executive Officer of Ceva, commented, “We delivered a strong start to 2026, highlighted by our highest licensing and related revenues in three years and continued momentum across our connectivity and AI portfolios. Importantly, this quarter reflects the successful execution of our strategy to expand beyond discrete IP into more integrated, system-level solutions. A major Bluetooth HDT licensing agreement, including RF, alongside our expansion in 5G NTN and Ultra-Wideband, demonstrates how we are increasing our value per design and deepening customer engagement. We also saw encouraging trends in royalties, with continued strength across our smart edge markets, partially offset by softness in smartphones.”
“In AI, our growth strategy and relentless focus on market-leading innovation are translating into production, with our technology integrated into leading automotive platforms and entering mass-volume production. With AI contributing over 20% of licensing and related revenues and a strong pipeline of engagements, we believe we are well positioned as the industry accelerates toward hybrid AI and the expansion of Physical AI at the edge.”
Business and Market Highlights
During the first quarter, Ceva signed 14 IP licensing agreements across connectivity, AI, and satellite communications, including several multi-technology engagements aligned with its strategy to deliver more integrated, system-level solutions.
The company secured a major full-stack Bluetooth HDT solution license, marking a key milestone in expanding value per design and increasing royalty contribution, while helping customers reduce integration complexity and accelerate time-to-market. Additional wins included a Wi-Fi 7 design targeting consumer IoT, a Wi-Fi 6 / Bluetooth combo engagement with a leading edge-AI SoC platform provider, and multiple Bluetooth and Wi-Fi agreements.
Ceva also expanded into new connectivity domains, introducing its PentaG-NTN platform and progressing a satellite customer engagement to a more integrated baseband solution. In Ultra-Wideband, the company launched its next-generation platform and secured a new customer as adoption accelerates across industrial and automotive applications.
In AI, Ceva continued to expand its footprint with multiple licensing agreements and achieved a key production milestone, with its AI DSP and accelerator deployed in the Renesas R-Car V4H platform, now entering production in the 2026 Toyota RAV4. The company also announced a collaboration with NXP for its latest software-defined vehicle processors. AI represented more than 20% of licensing and related revenues in the quarter, reflecting strong growth and increasing contribution.
Across its markets, Ceva continues to see strong demand in IoT and AI-driven applications, with record Wi-Fi shipments and significant growth in cellular IoT. These trends, together with the shift toward more integrated, system-level solutions and increasing adoption of Bluetooth and Wi-Fi combo chips, are driving higher value per device and reinforcing the company’s long-term royalty growth model.
Other first quarter financial data: *
GAAP gross margin was 86%, in line with last yearGAAP operating loss was $5.1 million, as compared to a GAAP operating loss of $4.4 millionGAAP net loss was $4.5 million, as compared to a GAAP net loss of $3.3 millionGAAP diluted loss per share was $0.16, as compared to GAAP diluted loss per share of $0.14Non-GAAP gross margin was 87%, in line with last yearNon-GAAP operating income was $0.5 million, as compared to non-GAAP operating income of $0.3 millionNon-GAAP net income and non-GAAP diluted earnings per share were $1.1 million and $0.04, respectively, compared with non-GAAP net income and non-GAAP diluted earnings per share of $1.4 million and $0.06, respectively
*Unless otherwise stated, all comparisons are to first quarter 2025.
Yaniv Arieli, Chief Financial Officer of Ceva, added, “Our first quarter results reflect strong licensing execution and the continued progression toward higher-value, multi-technology engagements. This shift is driving improved economics per deal and strengthening the long-term royalty potential of our business. We also continue to see encouraging trends across our diversified end markets, particularly in IoT and AI-driven applications. We continue to manage the impact of a weaker U.S. dollar and are implementing measures to partially offset the resulting expenses.”
Ceva Conference Call
On May 11, 2026, Ceva management will conduct a conference call at 8:30 a.m. Eastern Time to discuss the operating performance for the quarter.
The conference call will be available via the following dial in numbers:
U.S. Participants: Dial 1-844-435-0316 (Access Code: Ceva)International Participants: Dial +1-412-317-6365 (Access Code: Ceva)
The conference call will also be available live via webcast at the following link: https://app.webinar.net/N8PRLk4oljM. https://app.webinar.net/ePpLk12BRaDhttps://app.webinar.net/GvAklQElMmjPlease go to the web site at least fifteen minutes prior to the call to register.
For those who cannot access the live broadcast, a replay will be available by dialing +1 855-669-9658 or +1 412-317-0088 (access code: 4033535) from one hour after the end of the call until 9:00 a.m. (Eastern Time) on May 18, 2026. The replay will also be available at Ceva’s web site at www.ceva-ip.com.
Forward-Looking Statements
This press release contains forward-looking statements that involve risks and uncertainties, as well as assumptions that if they materialize or prove incorrect, could cause the results of Ceva to differ materially from those expressed or implied by such forward-looking statements and assumptions. Forward-looking statements include statements about Ceva’s positioning for future growth and to serve as a foundational technology provider for intelligent, connected devices, licensing agreement wins, future industry demand, our market position for the future and future growth in the demand of our products, our forecast of financial measures for the following quarter and 2026, our long term targets and underlying assumptions, our future investments, expectations about future market, the success of our strategies and agreements, visibility into future revenue streams, and Ceva’s focus on expense management and profitability improvement. The risks, uncertainties and assumptions that could cause differing Ceva results include: the effect of intense industry competition; the ability of Ceva’s technologies and products incorporating Ceva’s technologies to achieve market acceptance; Ceva’s ability to meet changing needs of end-users and evolving market demands; the lengthy sales cycle for IP and related solutions; Ceva’s ability to diversify royalty streams and license revenues; geopolitical risks and instability, including the impact of tariffs and other trade measures and potential disruptions related to ongoing conflicts in the Middle East; and general market conditions and other risks relating to Ceva’s business and industry, including, but not limited to, those that are described from time to time in our SEC filings. Ceva assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
About Ceva, Inc.
Ceva powers the Smart Edge, bridging the digital and physical worlds to bring AI-driven products to life. Our Ceva AI fabric portfolio of silicon and software IP enables devices to Connect, Sense, and Infer – the essential capabilities for the intelligent edge. From 5G, cellular IoT, Bluetooth, Wi-Fi, and UWB connectivity to scalable Edge AI NPUs, AI DSPs, sensor fusion processors and embedded software, Ceva provides the foundational IP for devices that connect, understand their environment, and act in real time.
With more than 21 billion devices shipped and trusted by 400+ customers worldwide, Ceva is the backbone of today’s most advanced smart edge products – from AI-infused wearables and IoT devices to autonomous vehicles and 5G infrastructure. Our differentiated solutions deliver seamless integration into existing design flows, total flexibility to combine solutions based on design needs and ultra–low–power performance in minimal silicon footprint, helping customers accelerate development, reduce risk, and bring innovative products to market faster. As technology evolves toward Physical AI, Ceva’s IP portfolio lays the foundation for systems that are always connected, contextually aware, and capable of intelligent, real-time decision-making.
Visit us at www.ceva-ip.com and follow us on LinkedIn, X, YouTube, Facebook, and Instagram.
CEVA, INC. AND ITS SUBSIDIARIES
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF LOSS – U.S. GAAP
U.S. dollars in thousands, except per share data
Three months ended
March 31,
2026
2025
Unaudited
Unaudited
Revenues:
Licensing and related revenues
$ 17,820
$ 15,042
Royalties
9,204
9,203
Total revenues
27,024
24,245
Cost of revenues
3,729
3,487
Gross profit
23,295
20,758
Operating expenses:
Research and development, net
19,837
17,609
Sales and marketing
3,766
3,449
General and administrative
4,660
3,933
Amortization of intangible assets
117
149
Total operating expenses
28,380
25,140
Operating loss
(5,085)
(4,382)
Financial income, net
1,877
2,100
Remeasurement of marketable equity securities
64
(54)
Loss before taxes on income
(3,144)
(2,336)
Income tax expense
1,315
991
Net loss
$ (4,459)
$ (3,327)
Basic and diluted net loss per share
$ (0.16)
$ (0.14)
Weighted-average shares used to compute net loss
per share (in thousands):
Basic and diluted
27,678
23,764
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
U.S. dollars in thousands, except per share data
Three months ended
March 31,
2026
2025
Unaudited
Unaudited
GAAP net loss
$ (4,459)
$ (3,327)
Equity-based compensation expense included in cost of
revenues
182
159
Equity-based compensation expense included in research
and development expenses
2,863
2,466
Equity-based compensation expense included in sales
and marketing expenses
717
566
Equity-based compensation expense included in general
and administrative expenses
1,610
1,132
Amortization of intangible assets related to acquisition of
businesses
176
208
Costs associated with asset acquisition
61
144
Loss (income) associated with the remeasurement of
marketable equity securities
(64)
54
Non-GAAP net income
$ 1,086
$ 1,402
GAAP weighted-average number of Common Stock
used in computation of diluted net loss per share (in
thousands)
27,678
23,764
Weighted-average number of shares related to
outstanding stock-based awards (in thousands)
1,810
1,618
Weighted-average number of Common Stock used
in computation of diluted earnings per share, excluding the
above (in thousands)
29,488
25,382
GAAP diluted loss per share
$ (0.16)
$ (0.14)
Equity-based compensation expense
$ 0.19
$ 0.18
Amortization of intangible assets related to acquisition
of businesses
$ 0.01
$ 0.01
Costs associated with asset acquisition
$ 0.00
$ 0.01
Non-GAAP diluted earnings per share
$ 0.04
$ 0.06
Three months ended
March 31,
2026
2025
Unaudited
Unaudited
GAAP operating loss
$ (5,085)
$ (4,382)
Equity-based compensation expense included in
cost of revenues
182
159
Equity-based compensation expense included in
research and development expenses
2,863
2,466
Equity-based compensation expense included in
sales and marketing expenses
717
566
Equity-based compensation expense included in
general and administrative expenses
1,610
1,132
Amortization of intangible assets related to acquisition
of businesses
176
208
Costs associated with asset acquisition
61
144
Total non-GAAP operating income
$ 524
$ 293
Three months ended
March 31,
2026
2025
Unaudited
Unaudited
GAAP gross profit
$ 23,295
$ 20,758
GAAP gross margin
86 %
86 %
Equity-based compensation expense included in
cost of revenues
182
159
Amortization of intangible assets related to acquisition
of businesses
59
59
Total non-GAAP gross profit
23,536
20,976
Non-GAAP gross margin
87 %
87 %
Three months ended
March 31,
2026
2025
Unaudited
Unaudited
GAAP operating expenses
28,380
25,140
Equity-based compensation expense included in
research and development expenses
(2,863)
(2,466)
Equity-based compensation expense included in
sales and marketing expenses
(717)
(566)
Equity-based compensation expense included in
general and administrative expenses
(1,610)
(1,132)
Amortization of intangible assets related to acquisition
of businesses
(117)
(149)
Costs associated with asset acquisition
(61)
(144)
Total non-GAAP operating expenses
$ 23,012
$ 20,683
CEVA, INC. AND ITS SUBSIDIARIES
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS
(U.S. dollars in thousands)
March 31,
December 31,
2026
2025 (*)
Unaudited
Unaudited
ASSETS
Current assets:
Cash and cash equivalents
$ 21,367
$ 40,586
Marketable securities and short-term bank deposits
194,326
181,397
Trade receivables, net
17,737
19,495
Unbilled receivables
31,135
29,860
Prepaid expenses and other current assets
16,297
13,498
Total current assets
280,862
284,836
Long-term assets:
Severance pay fund
7,225
7,530
Deferred tax assets, net
274
257
Property and equipment, net
9,010
7,054
Operating lease right-of-use assets
17,190
17,486
Investment in marketable equity securities
119
55
Goodwill
58,308
58,308
Intangible assets, net
868
1,044
Other long-term assets
14,370
11,686
Total assets
$ 388,226
$ 388,256
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Trade payables
$ 2,388
$ 2,418
Deferred revenues
2,968
3,496
Accrued expenses and other payables
19,224
21,026
Operating lease liabilities
2,794
1,743
Total current liabilities
27,374
28,683
Long-term liabilities:
Accrued severance pay
7,428
7,690
Operating lease liabilities
14,083
14,388
Other accrued liabilities
1,158
1,037
Total liabilities
50,043
51,798
Stockholders’ equity:
Common stock
28
28
Additional paid in-capital
343,298
337,966
Treasury stock
0
(1,591)
Accumulated other comprehensive income (loss)
(660)
79
Accumulated deficit
(4,483)
(24)
Total stockholders’ equity
338,183
336,458
Total liabilities and stockholders’ equity
$ 388,226
$ 388,256
(*) Derived from audited financial statements.
The Company believes that the presentation of non-GAAP measures in the press release is useful to investors in analyzing the results for the quarters ended March 31, 2026, and 2025 because the exclusion of the applicable expenses may provide a meaningful analysis of the Company’s core operating results and comparison of quarterly results. Further, the Company believes it is useful for investors to understand how the expenses associated with the application of FASB ASC No. 718 are reflected in its statements of income. The reconciliation of financial measures should be reviewed in addition to and in conjunction with results presented in accordance with GAAP and are intended to provide additional insight into the Company’s operations that, when viewed with its GAAP results and the accompanying reconciliation, offer a more complete understanding of factors and trends affecting the Company’s business. The reconciliation of financial measures should not be viewed as a substitute for the Company’s reported GAAP results.
A reconciliation of non-GAAP guidance to the corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty of expenses that may be incurred in the future, although it is important to note that these factors could be material to the Company’s results computed in accordance with GAAP.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ceva-inc-announces-first-quarter-2026-financial-results-302767706.html
SOURCE Ceva, Inc.
You may like
Technology
Honoring Dr. J. Craig Venter’s Legacy, Human Longevity Launches Clinical-Grade $599 Whole Genome Sequencing Report with AI-Enhanced Insights for Proactive Disease Prevention
Published
44 minutes agoon
May 11, 2026By
SOUTH SAN FRANCISCO, Calif., May 11, 2026 /PRNewswire/ — Human Longevity, Inc. today announced the launch of its new Clinical-Grade $599 Whole Genome Sequencing Report, designed to bring advanced genomic medicine and AI-driven disease prevention to the general population.
Despite major advances in medicine, most diseases today are still identified only after symptoms appear — often limiting opportunities for earlier intervention and prevention. While genomic sequencing has generated vast amounts of biological data, one of healthcare’s biggest challenges has been translating that data into actionable health insights at scale.
Human Longevity’s new offering honors the legacy of Dr. J. Craig Venter, whose pioneering work helped decode the first human genome and transform modern medicine.
More than two decades ago, the Human Genome Project required over $3 billion and years of international effort to decode a single human genome. Today, Human Longevity is making a clinical grade genome sequencing broadly accessible with a comprehensive AI-enhanced genomic insight platform for just $599.
Dr. Venter long predicted that the human genome would play an increasingly important role in managing individual health and preventing disease. In recent years, a growing body of global scientific research has continued to validate this vision, demonstrating that genomics is becoming a foundational tool for predicting disease risk, guiding prevention strategies, and enabling more personalized healthcare.
“Dr. Venter believed that genomics would fundamentally transform medicine from reactive sick care to a proactive healthcare model,” said Wei-Wu He, Ph.D. Executive Chairman of Human Longevity Inc. “A decade ago, he founded Human Longevity to combine whole genome sequencing with advanced imaging, including Whole Body MRI, multi-omics data, longitudinal health data and AI, to help people live longer, healthier lives. We are proud to continue that mission by democratizing access to decades of work led by Human Longevity.”
Over the last decade, Human Longevity has invested more than $600 million building one of the world’s most comprehensive longitudinal health datasets. The company has collected and analyzed data from more than 10,000 individuals over a 10-year period, enabling the development of proprietary AI-driven insights focused on major age-related chronic diseases such as cardiovascular disease, cancer, and dementia.
The new Clinical-Grade Whole Genome Sequencing Insight Report is designed to provide individuals with actionable insights into inherited disease risks, carrier status, pharmacogenomics, longevity-associated traits, and personalized disease prevention opportunities.
“Our vision is simple,” added Dr. He. “Every individual should have access to their genome and AI-powered health insights. The genome is the foundation of modern preventive medicine.”
The new service will be available nationwide immediately through Human Longevity’s website.
For more information, visit:
About Human Longevity, Inc.
Founded in 2013, Human Longevity, Inc. is a biotechnology company at the forefront of integrating genomics, artificial intelligence, and multimodal diagnostics to extend human healthspan founded by genomics pioneer J. Craig Venter. HLI delivers comprehensive, data-driven evaluations designed to identify and mitigate disease risk long before symptoms arise. The company is committed to redefining healthcare through AI-driven proactive diagnostics and personalized preventive care.
To learn more, visit http://www.humanlongevity.com/.
Media Contact:
media@humanlongevity.com
www.humanlongevity.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/honoring-dr-j-craig-venters-legacy-human-longevity-launches-clinical-grade-599-whole-genome-sequencing-report-with-ai-enhanced-insights-for-proactive-disease-prevention-302768424.html
SOURCE Human Longevity, Inc.
Technology
DocuPet Launches AnimalsFirst Integration to Increase Pet Protection Nationwide
Published
44 minutes agoon
May 11, 2026By
SYRACUSE, N.Y., May 11, 2026 /PRNewswire/ — DocuPet is proud to announce a new strategic partnership with AnimalsFirst, marking the official launch of an integrated solution designed to connect animal welfare organizations directly with DocuPet’s National Pet Registry. This collaboration represents a significant milestone in DocuPet’s long-term vision to streamline shelter operations while expanding pet registration across North America.
For several years, DocuPet has invested in building a flexible, scalable software infrastructure capable of supporting integrations with leading shelter management systems. With the continued growth of the National Pet Registry and the National Animal Shelter Network (NASN), DocuPet is now positioned to activate these capabilities AnimalsFirst offers a highly customizable shelter management platform that supports adoptions, foster coordination, medical tracking, and field services for approximately 120 animal welfare organizations. Through this partnership, shelter partners using AnimalsFirst will be able to directly register adopters and their pets into the National Pet Registry through a streamlined backend integration.
Expanding Protection Through the National Pet Registry
At the core of this partnership is a shared commitment to increasing the number of pets enrolled in DocuPet’s National Pet Registry. Registration is a critical step in protecting pets, ensuring that accurate, up-to-date ownership information is readily accessible when a lost animal is found.
DocuPet’s HomeSafe® service plays a vital role in this effort. Each registered pet receives a free tag with a unique code linked to its secure online profile. When a lost pet is found, anyone can use the information on the tag to quickly initiate the reunification process. This immediate connection dramatically improves return-to-home rates and reduces the time pets spend in shelters.
Getting visible identification tags on pets is one of the simplest yet most effective ways to keep animals safe, and the success is multiplied when using DocuPet tags that offer superior reunification benefits. By increasing registration at the point of adoption and throughout the community, DocuPet and its partners are helping ensure more pets have the protection they need.
“We are thrilled to partner with AnimalsFirst and to be able to offer our registration program to shelters and pet owners utilizing their platform,” said Jackie Rose, CSO of DocuPet. “This enhanced and streamlined process will allow pet owners to easily register to receive the protection benefits of having a free pet identification tag, connected to our 24/7 lost pet recovery system.”
Strengthening the Animal Welfare Ecosystem
This integration supports a broader, interconnected animal welfare ecosystem that includes pet owners, shelters, and animal control agencies. For pet owners, it provides peace of mind and an easy way to safeguard their animals. For shelters, it helps reduce overcrowding and administrative burden by increasing successful reunifications. For animal control officers, it offers a fast, reliable method to identify and return lost pets in the field.
By embedding registration opportunities directly into shelter workflows, DocuPet and AnimalsFirst are helping create a more proactive, efficient system; one that prioritizes prevention, accelerates reunification, and ultimately improves outcomes for animals and the communities that care for them.
This partnership underscores DocuPet’s commitment to leveraging technology to support animal welfare organizations, reduce administrative burden, and ensure more pets are protected through reliable identification and recovery services.
About DocuPet
DocuPet is the largest and fastest-growing pet registration and reunification platform in North America, providing official pet licensing services to more than 300 jurisdictions. DocuPet provides free lost pet services through HomeSafe®, and a unique product offering with an AI-powered pet tracker, designer pet tags, and other pet products/services. DocuPet is transforming how communities support animal welfare through inventive thinking and pioneering technology.
About AnimalsFirst
AnimalsFirst is a customizable shelter management software platform designed to support the operational needs of animal welfare organizations, including adoption management, foster coordination, medical tracking, and field services.
For more information, visit https://partnerships.docupet.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/docupet-launches-animalsfirst-integration-to-increase-pet-protection-nationwide-302767346.html
SOURCE DocuPet
Technology
Boundary Labs Announces $2M Pre-Seed Led by Galaxy Ventures to Launch Verifiable Institutional Stablecoin, USBD
Published
44 minutes agoon
May 11, 2026By
The current stablecoin landscape often forces institutions to rely on trust in opaque centralized models, off-chain systems, and reserves. Boundary is solving this by introducing a protocol where verifiability is the core product feature.
NEW YORK, May 11, 2026 /PRNewswire/ — Boundary today announced the closing of a $2M USD pre-seed funding round led by Galaxy Ventures. Joining the round are a cohort of leading institutional finance partners and angels, including VCs BlackWood and FirstBlock Capital. The capital will accelerate the launch of USBD, a novel stablecoin protocol engineered specifically for financial and blockchain institutions and approved participants who require a new standard of on-chain verifiability in the >$300B stablecoin market.
“Trust but verify” is a phrase core to the on-chain industry as it champions a critical principle where institutions and retail should not just trust but also verify that what a protocol says and offers is real. Without real verifiable, there is no real trust. This is paramount to the industry’s security, stability, and scalability. However, the current stablecoin landscape often forces institutions to rely on trust rather than working with immediately verifiable products and reserves.
Boundary is solving this by introducing a protocol where verifiability is the core product feature. By providing institutional counterparties with clear technical documentation and a framework for verifiability of reserves and stablecoin performance, Boundary allows institutions to move on-chain with the certainty required for large-scale institutional stablecoin use cases like treasury management, regulated wrappers, and on-chain collateral.
The Boundary Protocol introduces a sophisticated structure designed for institutional compliance and operational clarity:
On-chain Verifiability: Unlike first generation stablecoins, USBD is built for continuous auditability of financial fundamentals, providing institutions with the data-driven confidence needed for professional participation and fiduciary products.Institutional-Only Onboarding: Access will be facilitated through a dedicated dApp designed for rigorous KYC and KYB workflows, ensuring only qualifying institutional participants enter the ecosystem in the institutional growth phase.Strategic Ecosystem Support: As a participant in several institutional partnerships, soon to be announced, and having completed a security audit by Cyfrin, Boundary has quickly positioned itself as the project with the leading technology to ensure protocol integrity.
“Boundary represents a proposition that speaks the language of institutional finance,” said Matthew Mezger, Co-Founder of Boundary. “By prioritizing verifiability and partnering with Galaxy Ventures, we are providing the professional-grade infrastructure necessary to reach our initial milestone of $100M in Total Value Locked (TVL) in 2026”.
Following today’s announcement, and building on a successful proof-of-concept for the protocol’s self-funding capability through derisked decentralized market participation, Boundary will initiate a Private Placement Campaign to onboard initial institutional partners.
“Institutional adoption of stablecoins is not only well underway but already proving its value in real-world use cases. With a long runway of growth still ahead, unlocking the full potential of stablecoins requires infrastructure that is not just secure, but inherently verifiable,” said Danny Slutsky, Investor at Galaxy Ventures. “Boundary’s focus on professional participants and its goal to bridge the gap between traditional finance and blockchain makes it a promising player in growing the stablecoin market.”
About Boundary: Boundary Labs is mandated by the Boundary Foundation and Boundary OpCo to lead the design, development, and commercial representation of the Boundary project. Based in New York City, the firm provides financial institutions and professional participants with secure, verifiable access to the USBD stablecoin and the broader Boundary Protocol ecosystem. For more information, visit https://boundary.finance/.
View original content to download multimedia:https://www.prnewswire.com/news-releases/boundary-labs-announces-2m-pre-seed-led-by-galaxy-ventures-to-launch-verifiable-institutional-stablecoin-usbd-302767720.html
SOURCE Boundary Labs International, Inc.
Honoring Dr. J. Craig Venter’s Legacy, Human Longevity Launches Clinical-Grade $599 Whole Genome Sequencing Report with AI-Enhanced Insights for Proactive Disease Prevention
DocuPet Launches AnimalsFirst Integration to Increase Pet Protection Nationwide
Boundary Labs Announces $2M Pre-Seed Led by Galaxy Ventures to Launch Verifiable Institutional Stablecoin, USBD
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Coin Market5 days agoAave liquidates Kelp DAO hacker’s rsETH positions on Ethereum, Arbitrum
-
Coin Market5 days ago
Three reasons why Ether price rallies fizzle near $2.4K
-
Coin Market5 days ago
Bitcoin market dominance moves above 61%: Will altcoins follow?
-
Coin Market5 days agoJPMorgan, Mastercard make first cross-border US Treasury transfer via XRP Ledger
-
Coin Market5 days ago
Stablecoin adoption to scale on back of ‘very large’ tech firms: Bitwise
-
Coin Market4 days agoChangelly report highlights growing stablecoin use in everyday spending ahead of May 15 infrastructure discussion
-
Near Videos4 days agoMicrosoft and OpenAI restructure their deal and Anthropic ships Claude for creative tools!
-
Coin Market3 days agoAptos Foundation, Aptos Labs commit $50M to development as it eyes AI agent future
